You just read:

GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to DAS Therapeutics

News provided by

GT Biopharma, Inc.

Sep 24, 2019, 07:30 ET